RHOBTB2 and acute myeloid leukemia: Here, we applied bioinformatics analyses to determine the expression of RHOBTB genes in AML patients based on large-scale gene expressions in copy numbers published online and validate RHOBTB2 as an independent prognostic indicator and a tumor biomarker.